Copyright
©The Author(s) 2019.
World J Hepatol. Dec 27, 2019; 11(12): 752-760
Published online Dec 27, 2019. doi: 10.4254/wjh.v11.i12.752
Published online Dec 27, 2019. doi: 10.4254/wjh.v11.i12.752
Table 1 Reported causes of post-infantile giant cell hepatitis
Infectious | Hepatitis A, B, C |
Epstein-Barr virus (EBV) | |
Cytomegalovirus (CMV) | |
Paramyxo-like virus | |
Human immunodeficiency virus (HIV) | |
Herpesvirus 6A | |
Human papillomavirus (HPV) | |
Autoimmune | Autoimmune hepatitis (AIH) |
Ulcerative colitis (UC) | |
Primary sclerosing cholangitis (PSC) | |
Primary biliary cholangitis (PBC) | |
Systemic lupus erythematosus (SLE) | |
Rheumatoid arthritis (RA) | |
Polyarteritis nodosa (PAN) | |
Drugs | Methotrexate |
6 mercaptopurine | |
Amytriptyline | |
P-aminosalicylic acid | |
Vinyl chloride | |
Chropromazine | |
Methotrexate | |
Hematologic | Chronic lymphocytic leukemia (CLL) |
Lymphoma | |
Sickle cell disease (SCC) | |
Hypereosinophilia | |
Autoimmune hemolytic anemia | |
Endocrine | Hypoparathyroidism |
Infiltrative | Sarcoidosis |
Post-transplant | - |
Idiopathic | - |
- Citation: Matta B, Cabello R, Rabinovitz M, Minervini M, Malik S. Post-infantile giant cell hepatitis: A single center’s experience over 25 years. World J Hepatol 2019; 11(12): 752-760
- URL: https://www.wjgnet.com/1948-5182/full/v11/i12/752.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i12.752